SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: D Edwards who wrote (3666)12/15/1997 10:15:00 PM
From: Edderd  Read Replies (1) of 23519
 
This is a strange post. I am a urologist in an eight man practice and our experience is nowhere like the what is referenced above. Not only does MUSE work well for organic impotence (peer reviewed studies for post radical prostatectomy and diabetic impotence) but our refill rate is over 50% at the prsent time. All impotence medications will work on psychogenic impotence but that is not the point. This urologist is gaming the system by having the patients come back for four visits to titrate the dose. We let the patient do the dosing at home where it is likely to do the most good. After four visits to the urologist at the wrong dose many people will give up. Automatic rejection.
Ed
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News